Back to Search
Start Over
Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality.
- Source :
- Frontiers in immunology, 13
- Publication Year :
- 2022
-
Abstract
- Chemerin is an extracellular protein with chemotactic activities and its expression is increased in various diseases such as metabolic syndrome and inflammatory conditions. Its role in lung pathology has not yet been extensively studied but both known pro- and anti-inflammatory properties have been observed. The aim of our study was to evaluate the involvement of the chemerin/ChemR23 system in the physiopathology of COVID-19 with a particular focus on its prognostic value.<br />SCOPUS: ar.j<br />info:eu-repo/semantics/published
Details
- Database :
- OAIster
- Journal :
- Frontiers in immunology, 13
- Notes :
- 1 full-text file(s): application/pdf, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1356658366
- Document Type :
- Electronic Resource